RxDoctor Payments Data

Brian Saunders, OD

Optometrist · Marietta, GANPI 1912974700

Payments from drug & device makers

$545in general payments, 2019–2025

Across 26 payments — averaging $20.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$134
  • Novartis$96
  • AbbVie$93
  • Bausch & Lomb Americas Inc.$75
  • Oyster Point Pharma, Inc.$40
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$29
  • plus $79 from 4 others

What the payments were for

  • Food & beverage$545100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$545 in reported general payments places this provider in the 40th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia

Medicare billing

Part B allowed, 2024
$58,873
Medicare patients
400
Services billed
630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine46$45,616
Cyclosporine18$12,818
CequaCyclosporine12$11,317
Loteprednol Etabonate16$2,967
Travoprost17$1,841
Latanoprost127$1,551
Fluorometholone17$921
Prednisolone Acetate14$561
Timolol Maleate41$436
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat18$246
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha18$198
ErythromycinErythromycin Base17$180
Brimonidine Tartrate12$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis$93$45,61646 claims
Sun Pharmaceutical Industries Inc.Cequa$134$11,31712 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$29$2,96716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,285 optometrist providers in Georgia.

Other optometrist in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →